Safe and effective barrier against contamination during TSCPC
Using a sterile, disposable barrier for the G-probe transsceleral cyclophotocoagulation (TSCPC) device is a safe and effective method of preventing contamination in consecutive patients.
Using a sterile, disposable barrier for the G-probe transsceleral cyclophotocoagulation (TSCPC) device is a safe and effective method of preventing contamination in consecutive patients, according to a study published in the Journal of Glaucoma.
An investigation led by Dr Daniel B. Rootman, University of Toronto, Canada, measured diode laser output with and without the G-probe barrier both pre- and post- TSCPC. After each test, the barrier was inspected for microperforations and debris. Microbiology was recorded on the cadaver eye and after 20 cycles of the G-probe.
It was found that there was a statistically significant difference between the diode laser output with and without the G-probe barrier both pre- and post- TSCPC and the laser focus dispersion was reduced by the G-probe cover.
However, when using the G-probe barrier the clinicians found no evident perforations or any debris on the G-probe post-treatment.
Therefore, it was concluded that use of the barrier was effective when trying to avoid contamination during TSCPC.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.
